G protein-coupled receptors activate p38 MAPK via a non-canonical TAB1-TAB2- and TAB1-TAB3-dependent pathway in

Neil J Grimsey1, Ying Lin1, Rachan Narala1

  • 1From the Department of Pharmacology, University of California, San Diego, La Jolla, California 92093.

Insights

Multiple G protein-coupled receptor agonists activate p38 MAPK through non-canonical pathways involving TAB1-TAB2 and TAB1-TAB3, promoting endothelial inflammation. This reveals new mechanisms underlying endothelial dysfunction.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Immunology
  • Cardiovascular Research

Background:

  • Endothelial dysfunction, a precursor to cardiovascular diseases, is often triggered by inflammatory mediators acting through G protein-coupled receptors (GPCRs).
  • The precise GPCR signaling pathways driving endothelial dysfunction, particularly p38 mitogen-activated protein kinase (MAPK) activation, remain incompletely elucidated.
  • Previous research identified a non-canonical pathway for thrombin-induced p38 MAPK activation in endothelial cells, bypassing the conventional three-tiered kinase cascade.

Purpose of the Study:

  • To investigate whether various GPCR agonists activate p38 MAPK through the non-canonical pathway in human endothelial cells from diverse vascular beds.
  • To identify the specific TAB (T-LAK cell-originated protein kinase inhibitor) proteins involved in non-canonical p38 MAPK activation by different GPCR agonists.
  • To determine the role of these non-canonical pathways in mediating GPCR-induced inflammatory responses, such as interleukin-6 production.

Main Methods:

  • Utilized primary human umbilical vein endothelial cells (HUVECs), EA.hy926 cells, and human dermal microvascular endothelial cells (HDMECs).
  • Assessed p38 MAPK autophosphorylation and phosphorylation of upstream kinases (MKK3, MKK6) following stimulation with GPCR agonists (thrombin, histamine, prostaglandin E2, ADP).
  • Investigated the involvement of TAB1, TAB2, and TAB3 in p38 MAPK activation and interleukin-6 production using knockdown or inhibition strategies.

Main Results:

  • Multiple GPCR agonists, including thrombin, histamine, prostaglandin E2, and ADP, induced robust p38 MAPK autophosphorylation without significant MKK3/MKK6 phosphorylation, suggesting non-canonical activation.
  • Both non-canonical (TAB1/TAB2/TAB3) and canonical p38 pathway components are expressed in different human endothelial cell types.
  • Specific TAB protein requirements varied by cell type and agonist: thrombin and histamine primarily used TAB1-TAB2 in EA.hy926 cells, TAB1-TAB2 and TAB1-TAB3 in HUVECs, and TAB1-TAB3 (thrombin) or TAB1-TAB2 (histamine) in HDMECs.
  • Both TAB1-TAB2 and TAB1-TAB3 were essential for thrombin- and histamine-stimulated interleukin-6 production in HUVECs.

Conclusions:

  • Multiple GPCR agonists can activate p38 MAPK via non-canonical pathways dependent on TAB1-TAB2 and/or TAB1-TAB3 in human endothelial cells.
  • These non-canonical pathways play a significant role in mediating endothelial inflammatory responses, such as cytokine production.
  • The findings highlight the complexity of GPCR signaling in endothelial cells and identify novel therapeutic targets for inflammatory conditions.

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.9K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.9K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.4K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.6K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.4K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
4.1K